| Base excision repair in yeast and mammals A Memisoglu, L Samson Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 451 (1 …, 2000 | 422 | 2000 |
| Interaction between a peroxisome proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass A Memisoglu, FB Hu, SE Hankinson, JAE Manson, I De Vivo, WC Willett, ... Human molecular genetics 12 (22), 2923-2929, 2003 | 264 | 2003 |
| Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial M Fava, A Memisoglu, ME Thase, JA Bodkin, MH Trivedi, M De Somer, ... American Journal of Psychiatry 173 (5), 499-508, 2016 | 181 | 2016 |
| O6-alkylguanine DNA lesions trigger apoptosis. W Meikrantz, MA Bergom, A Memisoglu, L Samson Carcinogenesis 19 (2), 369-372, 1998 | 169 | 1998 |
| Genetic variation at the adiponectin locus and risk of type 2 diabetes in women FB Hu, A Doria, T Li, JB Meigs, S Liu, A Memisoglu, D Hunter, ... Diabetes 53 (1), 209-213, 2004 | 151 | 2004 |
| Injectable extended‐release naltrexone (XR‐NTX) for opioid dependence: long‐term safety and effectiveness E Krupitsky, EV Nunes, W Ling, DR Gastfriend, A Memisoglu, ... Addiction 108 (9), 1628-1637, 2013 | 145 | 2013 |
| Human lymphocytes exposed to low doses of X-rays are less susceptible to radiation-induced mutagenesis KT Kelsey, A Memisoglu, D Frenkel, HL Liber Mutation Research Letters 263 (4), 197-201, 1991 | 141 | 1991 |
| Contribution of base excision repair, nucleotide excision repair, and DNA recombination to alkylation resistance of the fission yeast Schizosaccharomyces pombe A Memisoglu, L Samson Journal of bacteriology 182 (8), 2104-2112, 2000 | 113 | 2000 |
| Prospective Study of the Association Between the Proline to Alanine Codon 12 Polymorphism in the PPARγ Gene and Type 2 Diabetes A Memisoglu, FB Hu, SE Hankinson, S Liu, JB Meigs, DM Altshuler, ... Diabetes Care 26 (10), 2915-2917, 2003 | 94 | 2003 |
| A placebo‐controlled pilot study of the novel opioid receptor antagonist ALKS‐33 in binge eating disorder SL McElroy, AI Guerdjikova, TJ Blom, SJ Crow, A Memisoglu, ... International Journal of Eating Disorders 46 (3), 239-245, 2013 | 69 | 2013 |
| Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies M Fava, ME Thase, MH Trivedi, E Ehrich, WF Martin, A Memisoglu, ... Molecular psychiatry 25 (7), 1580-1591, 2020 | 66 | 2020 |
| Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor γ gene with breast cancer and body mass A Memisoglu, SE Hankinson, JAE Manson, GA Colditz, DJ Hunter Pharmacogenetics and Genomics 12 (8), 597-603, 2002 | 65 | 2002 |
| Treating opioid dependence with injectable extended-release naltrexone (XR-NTX): who will respond? EV Nunes, E Krupitsky, W Ling, J Zummo, A Memisoglu, BL Silverman, ... Journal of addiction medicine 9 (3), 238-243, 2015 | 57 | 2015 |
| A phase 4, pilot, open-label study of VIVITROL®(extended-release naltrexone XR-NTX) for prisoners MS Gordon, TW Kinlock, FJ Vocci, TT Fitzgerald, A Memisoglu, ... Journal of Substance Abuse Treatment 59, 52-58, 2015 | 52 | 2015 |
| Safety and tolerability of SER-109 as an investigational microbiome therapeutic in adults with recurrent Clostridioides difficile infection: a phase 3, open-label, single-arm trial MD Sims, S Khanna, P Feuerstadt, TJ Louie, CR Kelly, ES Huang, ... JAMA Network Open 6 (2), e2255758-e2255758, 2023 | 51 | 2023 |
| A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers BL Silverman, W Martin, A Memisoglu, L DiPetrillo, CU Correll, JM Kane Schizophrenia research 195, 245-251, 2018 | 50 | 2018 |
| Cloning and characterization of a cDNA encoding a 3-methyladenine DNA glycosylase from the fission yeast Schizosaccharomyces pombe A Memisoglu, L Samson Gene 177 (1-2), 229-235, 1996 | 49 | 1996 |
| Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection MC Mitchell Jr, A Memisoglu, BL Silverman Journal of studies on alcohol and drugs 73 (6), 991-997, 2012 | 48 | 2012 |
| Open-label study of injectable extended-release naltrexone (XR-NTX) in healthcare professionals with opioid dependence PH Earley, J Zummo, A Memisoglu, BL Silverman, DR Gastfriend Journal of addiction medicine 11 (3), 224-230, 2017 | 27 | 2017 |
| Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3) JM Zajecka, AD Stanford, A Memisoglu, WF Martin, S Pathak Neuropsychiatric Disease and Treatment, 795-808, 2019 | 26 | 2019 |
